Considering the Patient in Pediatric Drug Development Ebook Tooltip How Good Intentions Turned Into Harm

Afbeeldingen
Inkijkexemplaar
Artikel vergelijken
  • Engels
  • E-book
  • 9780128242056
  • 19 november 2020
  • Adobe ePub
Alle productspecificaties
  • Je leest ebooks gemakkelijk op je Kobo e-reader, of op je smartphone of tablet met de bol.com Kobo app. Let op! Ebooks kunnen niet geannuleerd of geretourneerd worden.

Samenvatting

Considering the Patient in Pediatric Drug Development: How Good Intentions Turned into Harm addresses a fundamental challenge in drug development and healthcare for young patients. In clinical trials and clinical practice, the term "children" is used ambiguously to confer physiological characteristics to a chronological age limit, which in reality does not exist. This book outlines why the United States (US) and European Union's (EU) regulatory authorities, pediatric academia, and the pharmaceutical industry demand, support and perform pediatric drug studies, along with the key flaws of this demand that blurs the different administrative and physiological meanings of the term "child."

In addition, the book covers why most pediatric regulatory studies lack medical sense and many even harm young patients and the conflicts of interest behind pediatric drug studies. It includes relevant information about the maturation of the human body regarding absorption, distribution, metabolism and excretion of food and drugs as well as key differences between newborns, infants, older children and adolescents.

  • Explains relevant information about the maturation of the human body regarding absorption, distribution, metabolism and excretion of food and drugs, including key differences between newborns, infants, older children and adolescents
  • Discusses historical roots of separate drug approval in officially labeled "children" and conflicts of interest in performing and publishing "pediatric" research
  • Helps to decipher justifications for pediatric studies to help people navigate the relevance of the information

Productspecificaties

Inhoud

Taal
en
Bindwijze
E-book
Oorspronkelijke releasedatum
19 november 2020
Ebook Formaat
Adobe ePub

Betrokkenen

Hoofdauteur
Klaus Rose
Hoofduitgeverij
Academic Press

Lees mogelijkheden

Lees dit ebook op
Desktop (Mac en Windows) | Kobo e-reader | Android (smartphone en tablet) | iOS (smartphone en tablet) | Windows (smartphone en tablet)

Overige kenmerken

Studieboek
Nee

EAN

EAN
9780128242056

Je vindt dit artikel in

Beschikbaarheid
Leverbaar
Boek, ebook of luisterboek?
Ebook
Taal
Engels
Studieboek of algemeen
Studieboeken
Nog geen reviews
Kies gewenste uitvoering
Prijsinformatie en bestellen
De prijs van dit product is 127 euro en 99 cent.
Direct beschikbaar
Verkoop door bol
  • E-book is direct beschikbaar na aankoop
  • E-books lezen is voordelig
  • Dag en nacht klantenservice
  • Veilig betalen
Houd er rekening mee dat je downloadartikelen niet kunt annuleren of retourneren. Bij nog niet verschenen producten kun je tot de verschijningsdatum annuleren.
Zie ook de retourvoorwaarden